Identification of the O-Glycan Epitope Targeted by the Anti-Human Carcinoma Monoclonal Antibody (mAb) NEO-201
Precision Biologics, Inc. publishes paper on latest findings of the unique target that NEO-201 recognizes, in journal Cancers, Cancers 2022, 14(20), 4999; https://doi.org/10.3390/cancers14204999
✨The humanized monoclonal antibody NEO-201 recognizes and kills, through ADCC, target cells expressing core 1 or extended core 1 O-glycans, including human neutrophils, various #carcinomas and hematological malignancies✨
Find out more here👉https://t.co/5d6KCk8KZv pic.twitter.com/jvfzYYuWdL
— Cancers MDPI (@Cancers_MDPI) November 29, 2022